Skip to main content

Table 2 Preoperative and final postoperative clinical parameters for Cases 1–3

From: Bariatric surgery in individuals with human immunodeficiency virus and type 2 diabetes: a case series

  Case 1 Case 2 Case 3
preoperatively Postoperatively4 preoperatively Postoperatively4 preoperatively Postoperatively4
BMI (kg/m2) 44 37.8 48.1 37.9 47.9 41.1
Weight (kg) 152.1 132.1 142.2 112.0 118.0 101.2
% TWL1 6.6% 18.9% 5.1% 25.2% −0.2% 14.1%
% EWL2 14.3% 40.8% 10.0% 49.8% −0.4% 29.5%
HbA1c (mmol/mol)3 41 33 35 34 128 90
Diabetes medications Metformin 500 mg twice a day Metformin 500 mg twice a day Metformin 500 mg once a day Nil Metformin 1 g three times a day
Dapagliflozin 10 mg once a day
Exenatide 20 mcg once a day
Detemir 70 units twice a day
Metformin 1 g twice a day
Dapagliflozin 10 mg once a day
Humulin M3 (human insulin, mixture 3)
(22 units OM, 16 units ON)
CD4 count (cells/μL) 750 845 929 718 440 372
Viral load (cp/ml) < 40 < 40 < 40 < 20 < 40 < 20
HIV medications Atripla 1 Tab once a day Atripla (efavirenz/emtricitabine/tenofovir) 1 Tab once a day Atripla (efavirenz/emtricitabine/tenofovir) 1 Tab once a day Truvada (emtricitabine/tenofovir) 245/200 mg once a day
Raltegravir 400 mg twice a day
Truvada (emtricitabine/tenofovir) 245/200 mg once a day
Darunavir 800 mg once a day
Ritonavir 100 mg once a day
Truvada (emtricitabine/tenofovir) 245/200 mg once a day
Rezolsta (darunavir/cobicistat) 800/150 mg once a day
Complications   Vitamin D deficiency   Nil   Stricture
  1. BMI body mass index, EWL excessive weight loss, HbA1c glycated hemoglobin, HIV human immunodeficiency virus, Tab tablet, TWL total weight loss, OM in the morning, ON at night. 1 % TWL: percentage of total weight loss, 2 % EWL: percentage of excess weight loss, calculated by dividing weight changes from baseline by excess body weight. The latter value was obtained by subtracting the ideal body weight as that equivalent to a body mass index of 25 kg/m2 from the actual baseline weight, 3 normal range of glycated haemoglobin is 20–41 mmol/mol, 4 last follow-up (> 3 years in all cases)